tiprankstipranks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Holding ELTP?
Track your performance easily

Elite Pharmaceuticals (ELTP) Income Statement

255 Followers

Elite Pharmaceuticals Income Statement

Last quarter (Q2 2025), Elite Pharmaceuticals's total revenue was $18.88M, an increase of 33.36% from the same quarter last year. In Q2, Elite Pharmaceuticals's net income was $-11.04M. See Elite Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 71.17M$ 56.63M$ 34.16M$ 32.26M$ 25.38M$ 17.99M
Cost of Revenue
$ 39.34M$ 30.27M$ 17.56M$ 17.47M$ 13.51M$ 10.02M
Gross Profit
$ 31.83M$ 26.36M$ 16.59M$ 14.80M$ 11.87M$ 7.98M
Operating Expense
$ 17.22M$ 15.57M$ 12.92M$ 9.72M$ 9.76M$ 10.26M
Operating Income
$ 14.61M$ 10.79M$ 3.68M$ 5.07M$ 2.10M$ -2.29M
Net Non Operating Interest Income Expense
$ -317.40K$ -567.70K$ -1.11M$ 191.69K$ 684.82K$ -345.89K
Other Income Expense
$ 16.58M$ 5.78M$ -1.12M$ 1.43M$ -2.29M$ 9.69M
Pretax Income
$ -6.77M$ 463.09K$ 3.99M$ 6.30M$ 4.14M$ -2.24M
Tax Provision
$ -338.39K$ -19.60M$ 400.00K$ -1.74M$ -943.91K$ 100.00K
Earnings From Equity Interest Net Of Tax
----$ 48.46K-
Net Income Common Stockholders
$ -57.32M$ -30.82M$ -30.57M$ 8.90M$ 5.09M$ -2.24M
Basic EPS
-$ 0.02-$ 0.01$ 0.01-
Diluted EPS
-$ 0.02-$ 0.01$ 0.01-
Basic Average Shares
$ 4.17B$ 1.02B$ 1.01B$ 1.01B$ 943.00M$ 832.33M
Diluted Average Shares
$ 4.20B$ 1.02B$ 1.01B$ 1.01B$ 943.00M$ 993.26M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 56.56M$ 45.84M$ 30.48M$ 27.19M$ 23.28M$ 20.28M
Net Income From Continuing And Discontinued Operation
$ -6.39M$ 20.11M$ 3.56M$ 8.90M$ 5.09M$ -2.24M
Normalized Income
$ -11.24M--$ 4.57M$ 3.23M-
Interest Expense
------
EBIT
$ -6.35M$ 1.10M$ 5.07M$ 6.50M$ 4.40M$ -1.88M
EBITDA
$ -4.43M$ 2.57M$ 6.42M$ 7.93M$ 5.93M$ -371.88K
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis